ACOG recommends vaginal hysterectomy if patients need one, but only 25% are done that way. See how vNOTES, an advanced approach, could offer more patients less invasive surgery.
PARP-1 inhibitor drugs can reduce the risk of BRCA- and HRDS-associated ovarian cancer by 70%. New research at UT Southwestern Medical Center may help expand treatment to more patients.
Cancer death rates have dropped nearly 30% since 1991, and more that 2% between 2016 and 2017 alone – the biggest one-year drop on record. The driver has been precision medicine, an approach that focuses on personalization and collaboration. Learn more now.
